144 ·Filed Jun 5, 2026

STE

STERIS plc
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001921094-26-000609
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale following equity vesting — no material read-through for STE. The dollar amount is trivial relative to market cap and the insider's likely total holdings. Monitor for any unusual acceleration of insider sales, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
STE ▲ +9.27% at T+60d
NEUTRAL call ✓ call won +9.27% · α vs SPY +6.22% · entry $210.03 → $229.51
Entry anchored
Jun 5, 2026
via day open
T+1d
+1.36%
call +1.36% · α +1.65%
$212.88
settled 4mo ago
T+5d
-1.95%
call -1.95% · α -4.06%
$205.93
settled 4mo ago
T+20d
+1.55%
call +1.55% · α -0.08%
$213.28
settled 3mo ago
T+60d
+9.27%
call +9.27% · α +6.22%
$229.51
settled 4w ago

Price Chart

Loading chart...

Executive Summary

Daniel A. Carestio, an officer and director of STERIS plc, filed a Form 144 notice of intent to sell 1,374 ordinary shares with an estimated market value of $291,288. The shares were acquired on June 2, 2026, via a restricted stock lapse (equity compensation). This is a routine, small-dollar sale by an insider following a vesting event — not a material signal of concern.

Key Facts

  • Insider Daniel A. Carestio (Officer/Director) filed Form 144 to sell 1,374 ordinary shares.
  • Estimated market value of proposed sale: $291,288.
  • Shares acquired on June 2, 2026, via restricted stock lapse (equity compensation).
  • Sale intended to be executed through Charles Schwab & Co., Inc. on NYSE.
  • Filing date: June 5, 2026; proposed sale date: June 5, 2026.
  • Carestio also reported a separate sale of 3,054 shares on June 4, 2026, with an estimated value of $655,511.
  • Total shares sold or proposed to be sold in the past 3 months: 4,428 shares.

Financial Impact

Proposed sale of $291,288 (1,374 shares) plus a prior sale of $655,511 (3,054 shares) — total ~$946,799 over two transactions. Relative to a $20.7B market cap, this is negligible.

insider holdingsdilution

Risk Factors

  • Insider selling could increase if the stock price weakens or if additional restricted shares vest.
  • Historical calibration shows past neutral/high-score reports on STE had negative T+20 alpha — but this filing is too small to drive price action.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001921094-26-000609
Document: 0001921094-26-000609-index.html0001921094-26-000609
Document: 0001921094-26-000609.txt0001921094-26-000609
10 reports for STE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for STE — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
Press Release
NEUTRAL ★ 2/10
$230.34 $236.44▲ +2.65%▼ −0.73%$208.54 (−9.46%)
Jun 15, 2026
15w ago
144
NEUTRAL ★ 2/10
$206.51 $208.73▲ +1.07%▲ +0.88%$208.54 (+0.98%)
Jun 11, 2026
16w ago
DEFA14A
NEUTRAL ★ 2/10
$207.56 $216.00▲ +4.07%▲ +2.29%$208.54 (+0.47%)
Jun 8, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$212.88 $215.39▲ +1.18%▼ −0.27%$208.54 (−2.04%)
Jun 5, 2026
17w ago
144
NEUTRAL ★ 2/10
$210.03 $213.28▲ +1.55%▼ −0.08%$208.54 (−0.71%)
Jun 4, 2026
17w ago
144
NEUTRAL ★ 2/10
$212.35 $213.28▲ +0.44%▼ −1.42%$208.54 (−1.79%)
May 11, 2026
20w ago
8-K
BEARISH ★ 7/10
$210.23 $208.10▲ +1.01%▼ −0.71%$208.54 (+0.80%)
May 11, 2026
20w ago
Press Release
MIXED ★ 6/10
$210.23 $208.10▼ −1.01%▲ +0.71%$208.54 (−0.80%)
May 7, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$207.24 $212.35▲ +2.47%▲ +2.44%$208.54 (+0.63%)
Apr 21, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$222.61 $214.42▼ −3.68%▼ −6.84%$208.54 (−6.32%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (65h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access